TRANSCATHETER HEART VALVE REPAIR AND REPLACEMENT DEVICES

Tender description

NHS Supply Chain seeks to establish a non-exclusive framework agreement for the supply of percutaneous valve repair and replacement devices to NHS Supply Chain customers via the non-direct route of supply. Certain products within this framework agreement are classified as high cost tariff excluded devices under the NHS England High Cost Tariff Excluded Devices (HCTED) programme. Trusts who are commissioned to provide specialised services in England are directed to purchase all their requirements through a national supply system through NHS Supply Chain. It is anticipated that initial expenditure will be in the region of £130,000,000.00 to £170,000,000.00 in the first year of this framework agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement. The estimated value over the total framework agreement term is £810,000,000.00 Lot 1: Transcatheter Aortic Valve Implant (TAVI) System Products within this lot include, but are not limited to: transcatheter aortic valve implant systems including heart valves, loading systems and delivery systems. Certain products within this lot are classified as high cost tariff excluded devices under the NHS England High Cost Tariff Excluded Devices (HCTED) programme. Trusts who are commissioned to provide specialised services in England are directed to purchase all their requirements through a national supply system through NHS Supply Chain. Details of the product categories currently within scope of the HCTED programme, can be found using the following link: https://www.england.nhs.uk/commissioning/spec-services/key-docs/medicaldevices/ In accordance with the specialised services commissioning policy, NHS Improvement and NHS England will determine which products are classified as excluded from tariff and which are made available under the NHS England High Cost Tariff Excluded Devices (HCTED) programme. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £120,000,000.00 to £150,000,000.00 in the first year of this framework agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement. Additional information: Precise quantities are unknown. It is anticipated that expenditure for the initial term will be in the region of £104,000,000.00 of this Framework Agreement to £231,000,000.00 for the full term. However, these values are approximate only and may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Lot 2: Transcatheter Non-Aortic Valve/Chord Repair & Replacement Devices and Aortic & Non-Aortic Valve Accessories Products within this lot include, but are not limited to: transcatheter pulmonary valve, tricuspid and mitral valve implant systems (including heart valves, loading systems and delivery systems) and mitral, pulmonary and tricuspid valve repair products, mitral chordae tendineae repair Certain products within this lot are classified as high cost tariff excluded devices under the NHS England High Cost Tariff Excluded Devices (HCTED) programme. Trusts who are commissioned to provide specialised services in England are directed to purchase all their requirements through a national supply system through NHS Supply Chain. Details of the product categories currently within scope of the HCTED programme, can be found using the following link: https://www.england.nhs.uk/commissioning/spec-services/key-docs/medical devices. In accordance with the specialised services commissioning policy, NHS Improvement and NHS England will determine which products are classified as excluded from tariff and which are made available under the NHS England High Cost Tariff Excluded Devices (HCTED) programme. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of GBP 10 m to GBP 20 m in the first year of this framework agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement. Additional information: Precise quantities are unknown. It is anticipated that expenditure for the initial term will be in the region of £7,000,000.00 of this Framework Agreement to £11,000,000.00 for the full term. However, these values are approximate only and may vary depending on the requirements of those bodies purchasing under the Framework Agreement.